ReviewFrontiers in medicine2018
Parvovirus B19: What Is the Relevance in Transfusion Medicine?
Review in Frontiers in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 36 citations in OpenAlex.
- Multiple Mononeuropathy Secondary to Parvovirus B19 Infection: A Case Series.European journal of neurology · 2026Observational
- Insights into parvovirus B19 clinical and virological dynamics among blood donors.Le infezioni in medicina · 2026Article
- Long-Term Retrospective Analysis of Parvovirus B19 Infections in Blood Donors (2012-2024): Significant Increase in Prevalence Following the SARS-CoV-2 Pandemic.Diagnostics (Basel, Switzerland) · 2025Article
- Molecular and Serological Detection of Human Parvovirus B19 in a Sample of Iraqi Patients with Acute Lymphoid Leukemia in Relation to Hematological Parameters.Asian Pacific journal of cancer prevention : APJCP · 2025Article
- Discovery of a human parvovirus B19 analog (Erythroparvovirus) in cats.Scientific reports · 2025Article
- Comprehensive analysis of parvovirus B19 infection in blood donors: epidemiological trend and implications for transfusion safety and management strategies in Italy.Blood transfusion = Trasfusione del sangue · 2025Review
- Increased parvovirus B19 seropositivity in healthy blood donors in India.Scientific reports · 2024Article
- Detection and analysis of parvovirus B19 among blood donors in a regional blood center in Eastern China.Heliyon · 2024Article
- Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients.Pathogens (Basel, Switzerland) · 2023Review
- Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar.Viruses · 2021Article
- Human parvovirus B19-associated early postoperative acquired pure red cell aplasia in simultaneous pancreas-kidney transplantation: A case report.World journal of clinical cases · 2021Article
- Viral metagenomics in blood donations with post-donation illness reports from Brazil.Blood transfusion = Trasfusione del sangue · 2021Article
- PREVALENCE OF HUMAN PARVOVIRUS B19 IgG AND IgM ANTIBODIES AMONG PREGNANT WOMEN ATTENDING ANTENATAL CLINIC AT FEDERAL TEACHING HOSPITAL IDO-EKITI, NIGERIA.African journal of infectious diseases · 2021Article
- Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.Clinical microbiology reviews · 2020Review
- Article
- Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia.BMC infectious diseases · 2018Article
- Surveillance of blood donors detects an exceptional Parvovirus B19 outbreak in Switzerland in 2023/2024.Blood transfusion = Trasfusione del sangueArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parvovirus B19 (B19V) has been discovered in 1975. The association with a disease was unclear in the first time after the discovery of B19V, but meanwhile, the usually droplet transmitted B19V is known as the infectious agent of the "fifth disease," a rather harmless children's illness. But B19V infects erythrocyte progenitor cells and thus, acute B19V infection in patients with a high erythrocyte turnover may lead to a life-threatening aplastic crisis, and acutely infected pregnant women can transmit B19V to their unborn child, resulting in a hydrops fetalis and fetal death. However, in many adults, B19V infection goes unnoticed and thus many blood donors donate blood despite the infection. The B19V infection does not impair the blood cell counts in healthy blood donors, but after the acute infection with extremely high DNA concentrations exceeding 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.